NIH: stimulated but flat

The National Institutes of Health -- the happy recipient of about $10 billion from the recently-passed economic stimulus bill -- is staring down the barrel of another year of flat funding, according to the draft linkurl:FY2009 budget;http://appropriations.house.gov/FY2009_consolidated.shtml released yesterday by the House of Representatives. Image: linkurl:flickr/borman818;http://www.flickr.com/photos/dborman2/ The FY2009 Omnibus Appropriations Act includes a paltry 3% increase to NIH's FY200

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The National Institutes of Health -- the happy recipient of about $10 billion from the recently-passed economic stimulus bill -- is staring down the barrel of another year of flat funding, according to the draft linkurl:FY2009 budget;http://appropriations.house.gov/FY2009_consolidated.shtml released yesterday by the House of Representatives.

Image: linkurl:flickr/borman818;http://www.flickr.com/photos/dborman2/
The FY2009 Omnibus Appropriations Act includes a paltry 3% increase to NIH's FY2008 budget. The bill indicates that $30.3 billion will go to the NIH "for lifesaving research into diseases such as Alzheimer's, cancer and diabetes," which only amounts to a $938 million increase above 2008's budget, "so that NIH can capitalize on unprecedented scientific opportunities with almost 10,600 new research grants." Howard Garrison, a spokesperson for the Federation of American Societies for Experimental Biology (FASEB), told __The Scientist__ that the '09 NIH budget did not come as a surprise. "It's not a healthy increase," Garrison said, "but it is an increase. And it's what we were expecting." Other government science agencies fare a little better than the NIH in the bill. The Food and Drug Administration would get $2 billion, or $335 million above its 2008 budget, and the Centers for Disease Control and Prevention would receive $6.6 billion, $239 million above last year. National Science Foundation funding would be bumped by 7% to 6.9 billion, a reasonable increase given the $3 billion increase it received in the stimulus bill. The numbers may yet change as the bill gets tossed around the House and Senate floors before a final vote.
**__Related stories:__***linkurl:Flat funding for NIH in 2009;http://www.the-scientist.com/blog/display/55450/
[23rd February 2009]*linkurl:How to spend the NIH stimulus;http://www.the-scientist.com/blog/display/55413/
[11th February 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies